Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy-Reference-Cited by-同舟云学术

Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy

Published:2022 Issue:3 Volume:14 Page:632-641
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Ulfo Luca¹^ORCID,Cantelli Andrea²,Petrosino Annapaola¹^ORCID,Costantini Paolo Emidio¹^ORCID,Nigro Michela¹,Starinieri Francesco¹,Turrini Eleonora³^ORCID,Zadran Suleman Khan¹,Zuccheri Giampaolo¹,Saporetti Roberto²^ORCID,Di Giosia Matteo²^ORCID,Danielli Alberto¹,Calvaresi Matteo²^ORCID

Affiliation:

1. Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum – Università di Bologna, via Francesco Selmi 3, 40126 Bologna, Italy

2. Dipartimento di Chimica “Giacomo Ciamician”, Alma Mater Studiorum – Università di Bologna, Via Francesco Selmi 2, 40126 Bologna, Italy

3. Dipartimento di Scienze per la Qualità della Vita, Alma Mater Studiorum—Università di Bologna, Corso d'Augusto 237, 47921 Rimini, Italy

Abstract

Not all viruses are bad. We developed an orthogonal approach (genetic/chemical) to engineer M13 bacteriophages as targeted vectors for efficient photodynamic killing of cancer cells.

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NR/D1NR06053H

Reference83 articles.

1. Photodynamic therapy for cancer

2. How promising is phototherapy for cancer?

3. Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules